These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 37582935)

  • 21. The Fast Approval and Slow Rollout of Sputnik V: Why Is Russia's Vaccine Rollout Slower than That of Other Nations?
    Mikule E; Reissaar T; Villers J; Takoupo Penka AS; Temerev A; Rozanova L
    Epidemiologia (Basel); 2021 Aug; 2(3):360-376. PubMed ID: 36417231
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Factors influencing attitudes toward vaccine safety and vaccine effectiveness amongst UK healthcare professionals prior to and at the time of COVID-19 vaccine rollout: Insights from the CoPE-HCP cohort study.
    Collett G; Godec T; Gupta AK;
    Hum Vaccin Immunother; 2023 Dec; 19(1):2188823. PubMed ID: 36977613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The COVID-19 vaccine rollout and labor market recovery in the U.S: a note.
    Ogundari K
    SN Bus Econ; 2022; 2(7):75. PubMed ID: 35789709
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Publisher Correction to: The rollout of the COVID-19 vaccination: what can Canada learn from Israel?
    Marchildon GP
    Isr J Health Policy Res; 2021 Feb; 10(1):20. PubMed ID: 33637101
    [No Abstract]   [Full Text] [Related]  

  • 25. The changing vaccine landscape: rates of COVID-19 vaccine acceptance and hesitancy in young adults during vaccine rollout.
    Knight H; Jia R; Ayling K; Blake H; Morling JR; Villalon AM; Corner J; Denning C; Ball J; Bolton K; Figueredo G; Morris D; Tighe P; Vedhara K
    Perspect Public Health; 2023 Jul; 143(4):220-224. PubMed ID: 35575215
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Health and socio-demographic implications of the Covid-19 second pandemic wave in Israel, compared with the first wave.
    Birenbaum-Carmeli D; Chassida J
    Int J Equity Health; 2021 Jul; 20(1):154. PubMed ID: 34215274
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Public Officials' Engagement on Social Media During the Rollout of the COVID-19 Vaccine: Content Analysis of Tweets.
    Marani H; Song MY; Jamieson M; Roerig M; Allin S
    JMIR Infodemiology; 2023 Jul; 3():e41582. PubMed ID: 37315194
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Science and behavioral intentions among Israeli Jewish ultra-Orthodox males: Death from COVID-19 or from the COVID-19 vaccine? A thematic study.
    Gabay G; Tarabieh M
    Public Underst Sci; 2022 May; 31(4):410-427. PubMed ID: 35098797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vaccines and Public Trust: Containing COVID-19 in Cuba.
    Gorry C
    MEDICC Rev; 2022 Jan; 24(1):9-13. PubMed ID: 35157633
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influenza virus vaccine compliance among pregnant women during the COVID-19 pandemic (pre-vaccine era) in Israel and future intention to uptake BNT162b2 mRNA COVID-19 vaccine.
    Saleh OA; Halperin O
    Vaccine; 2022 Mar; 40(13):2099-2106. PubMed ID: 35193794
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Impact and effectiveness of mRNA BNT162b2 vaccine against SARS-CoV-2 infections and COVID-19 cases, hospitalisations, and deaths following a nationwide vaccination campaign in Israel: an observational study using national surveillance data.
    Haas EJ; Angulo FJ; McLaughlin JM; Anis E; Singer SR; Khan F; Brooks N; Smaja M; Mircus G; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet; 2021 May; 397(10287):1819-1829. PubMed ID: 33964222
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ethnic differences in COVID-19 mortality in the second and third waves of the pandemic in England during the vaccine rollout: a retrospective, population-based cohort study.
    Bosworth ML; Ahmed T; Larsen T; Lorenzi L; Morgan J; Ali R; Goldblatt P; Islam N; Khunti K; Raleigh V; Ayoubkhani D; Bannister N; Glickman M; Nafilyan V
    BMC Med; 2023 Jan; 21(1):13. PubMed ID: 36617562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of a COVID-19 Vaccine Rollout in a Highly Affected American Indian Community, San Carlos Apache Tribe, December 2020-February 2021.
    Le-Morawa N; Kunkel A; Darragh J; Reede D; Chidavaenzi NZ; Lees Y; Hoffman D; Dia L; Kitcheyan T; White M; Belknap I; Agathis N; Began V; Balajee SA
    Public Health Rep; 2023; 138(2_suppl):23S-29S. PubMed ID: 36017554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rollout of COVID-19 Vaccination in India: A SWOT Analysis.
    Sharma P; Pardeshi G
    Disaster Med Public Health Prep; 2021 Apr; ():1-4. PubMed ID: 33820581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness of a Third Dose of mRNA Vaccines Against COVID-19-Associated Emergency Department and Urgent Care Encounters and Hospitalizations Among Adults During Periods of Delta and Omicron Variant Predominance - VISION Network, 10 States, August 2021-January 2022.
    Thompson MG; Natarajan K; Irving SA; Rowley EA; Griggs EP; Gaglani M; Klein NP; Grannis SJ; DeSilva MB; Stenehjem E; Reese SE; Dickerson M; Naleway AL; Han J; Konatham D; McEvoy C; Rao S; Dixon BE; Dascomb K; Lewis N; Levy ME; Patel P; Liao IC; Kharbanda AB; Barron MA; Fadel WF; Grisel N; Goddard K; Yang DH; Wondimu MH; Murthy K; Valvi NR; Arndorfer J; Fireman B; Dunne MM; Embi P; Azziz-Baumgartner E; Zerbo O; Bozio CH; Reynolds S; Ferdinands J; Williams J; Link-Gelles R; Schrag SJ; Verani JR; Ball S; Ong TC
    MMWR Morb Mortal Wkly Rep; 2022 Jan; 71(4):139-145. PubMed ID: 35085224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spatial priority for COVID-19 vaccine rollout against limited supply.
    Sarkar SK; Morshed MM
    Heliyon; 2021 Nov; 7(11):e08419. PubMed ID: 34805560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness of a third BNT162b2 mRNA COVID-19 vaccination during pregnancy: a national observational study in Israel.
    Guedalia J; Lipschuetz M; Calderon-Margalit R; Cohen SM; Goldman-Wohl D; Kaminer T; Melul E; Shefer G; Sompolinsky Y; Walfisch A; Yagel S; Beharier O
    Nat Commun; 2022 Nov; 13(1):6961. PubMed ID: 36379951
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Knowledge, attitudes and perceptions of a patient population on the COVID-19 vaccine rollout.
    Purasram M; Bangalee V; Oosthuizen F; Moodley R
    Health SA; 2022; 27():1845. PubMed ID: 36570088
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infections, hospitalisations, and deaths averted via a nationwide vaccination campaign using the Pfizer-BioNTech BNT162b2 mRNA COVID-19 vaccine in Israel: a retrospective surveillance study.
    Haas EJ; McLaughlin JM; Khan F; Angulo FJ; Anis E; Lipsitch M; Singer SR; Mircus G; Brooks N; Smaja M; Pan K; Southern J; Swerdlow DL; Jodar L; Levy Y; Alroy-Preis S
    Lancet Infect Dis; 2022 Mar; 22(3):357-366. PubMed ID: 34562375
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vaccinating Australia: How long will it take?
    Hanly M; Churches T; Fitzgerald O; MacIntyre CR; Jorm L
    Vaccine; 2022 Apr; 40(17):2491-2497. PubMed ID: 34284875
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.